Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Anebulo Pharmaceuticals Inc (NQ: ANEB ) 1.980 +0.040 (+2.06%) Streaming Delayed Price Updated: 3:44 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Anebulo Pharmaceuticals Inc < Previous 1 2 3 Next > 12 Health Care Stocks Moving In Friday's Intraday Session June 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session May 31, 2024 Via Benzinga ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024 May 15, 2024 ANEB stock results show that Anebulo Pharmaceuticals beat analyst estimates for earnings per share the third quarter of 2024. Via InvestorPlace Substance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication Drug February 14, 2024 Substance use disorder-focused biopharmaceutical company Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported on Tuesday second quarter financial results for the three months ended Dec. 31, 2023, The... Via Benzinga Substance Use Disorder Focused Anebulo Could Be Attractive Acquisition Target, Analyst Says September 18, 2023 H.C. Via Benzinga Anebulo Pharmaceuticals: Q3 Earnings Insights May 11, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Wednesday October 19, 2022 On Wednesday, 200 companies hit new 52-week lows. Via Benzinga Lower Doses Of Anebulo's ANEB-001 Reduces Negative Effects Of Higher Doses Of THC September 26, 2022 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session December 21, 2023 Via Benzinga Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session October 17, 2023 Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session October 17, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023 September 18, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session August 22, 2023 Via Benzinga Anebulo Receives Positive Feedback From FDA On Path To Phase 3 Trial Of Its Drug For Acute Cannabinoid Intoxication August 21, 2023 Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) announced positive feedback from the United States Food and Drug Administration following a type B meeting in July. Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Monday's Pre-Market Session August 21, 2023 Via Benzinga Antidote For THC? Anebulo Releases Positive Clinical Data Showing Potential Of Its Drug For Treatment Of Acute Cannabinoid Intoxication March 29, 2023 Anebulo Pharmaceuticals, Inc. Via Benzinga Latest Executive Changes In Marijuana Industry, New Appointments & Resignations March 13, 2023 As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the mari Via Benzinga Acute Cannabinoid Intoxication: This Pharma Company's Clinical Trials To Reduce And Treat Symptoms January 09, 2023 Anebulo Pharmaceuticals, Inc. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session October 03, 2022 Gainers Via Benzinga Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 07, 2023 Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the... Via Benzinga Anebulo Pharma Posts FY 2022 Earnings, Positive Results From Clinical Trial For Treatment Of Acute Cannabinoid Intoxication September 09, 2022 Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse,... Via Benzinga Why Heart Test Laboratories Are Trading Higher By 136%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 30, 2023 Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 136% to $2.06 after Ascendant Capital initiated coverage on the stock with a Buy rating and a $3.30 price target. Via Benzinga Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session December 19, 2022 Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. Via Benzinga Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session December 06, 2022 Gainers Summit Therapeutics Inc. (NASDAQ: SMMT) shares surged 82.2% to $1.4299 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecific... Via Benzinga Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday November 02, 2022 Gainers Via Benzinga Stocks That Hit 52-Week Lows On Tuesday October 25, 2022 On Tuesday, 120 companies set new 52-week lows. Via Benzinga Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session October 25, 2022 Gainers Via Benzinga Stocks That Hit 52-Week Lows On Tuesday October 18, 2022 During Tuesday's session, 78 companies made new 52-week lows. Via Benzinga Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday October 04, 2022 Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per... Via Benzinga Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session October 03, 2022 Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.